Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism

Endocrine Reviews

Volumn 35, Issue 6, 2014, Pages 961-991

  Gore, Andrea C ^a   Martien, Katherine M ^b   Gagnidze, Khatuna ^c   Pfaff, Donald ^c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOMESTIC CHEMICAL; STEROID HORMONE; TESTOSTERONE; ENDOCRINE DISRUPTOR; HORMONE;

AUTISM; BEHAVIOR DISORDER; BLOOD PLACENTA BARRIER; BRAIN DEVELOPMENT; COMMUNICATION SKILL; CONGENITAL ADRENAL HYPERPLASIA; HUMAN; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; OVARY POLYCYSTIC DISEASE; PREGNANT WOMAN; PRENATAL DEVELOPMENT; REVIEW; SEX DIFFERENCE; SEX DIFFERENTIATION; SOCIAL BEHAVIOR; AUTISTIC DISORDER; BRAIN; DRUG EFFECTS; FEMALE; FETUS; FETUS DEVELOPMENT; GENETIC EPIGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

AUTISTIC DISORDER; BRAIN; ENDOCRINE DISRUPTORS; EPIGENESIS, GENETIC; FEMALE; FETAL DEVELOPMENT; FETUS; HORMONES; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84920085294     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2013-1122     Document Type: Review

References (279)

1. Ansbacher R. Interchangeability of low-dose oral contraceptives. Are current bioequivalent testing measures adequate to ensure therapeutic equivalency? Contraception. 1991;43:139-147.
2. Ansbacher R. Low-dose oral contraceptives: health consequences of discontinuation. Contraception. 2000;62:285-288.
3. Wu MV, Manoli DS, Fraser EJ, et al. Estrogen masculinizes neural pathways and sex-specific behaviors. Cell. 2009;139:61-72.
4. Biegon A, Kim SW, AlexoffDL, et al. Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole. Synapse. 2010;64:801-807.
5. Bakker J, De Mees C, Douhard Q, et al. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat Neurosci. 2006;9:220-226.
6. McCarthy MM. Sex and the Developing Brain. San Rafael, CA: Morgan & Claypool Life Sciences; 2011.
7. Davis EC, Popper P, Gorski RA. The role of apoptosis in sexual differentiation of the rat sexually dimorphic nucleus of the preoptic area. Brain Res. 1996;734:10-18.
8. Forger NG. Cell death and sexual differentiation of the nervous system. Neuroscience. 2006;138:929-938.
9. de Vries GJ, Södersten P. Sex differences in the brain: the relation between structure and function. Horm Behav. 2009;55:589-596.
10. Gorski RA, Harlan RE, Jacobson CD, Shryne JE, Southam AM. Evidence for the existence of a sexually dimorphic nucleus in the preoptic area of the rat. J Comp Neurol. 1980;193:529-539.
11. Gorski RA. Hypothalamic imprinting by gonadal steroid hormones. Adv Exp Med Biol. 2002;511:57-70; discussion 70-73.
12. Simerly RB. Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. Ann Rev Neurosci. 2002;25:507-536.
13. Cahill L. Why sex matters for neuroscience. Nat Rev Neurosci. 2006;7:477-484.
14. Roselli CE, Resko JA, Stormshak F. Expression of steroid hormone receptors in the fetal sheep brain during the critical period for sexual differentiation. Brain Res. 2006;1110:76-80.
15. Arnold AP, Gorski RA. Gonadal steroid induction of structural sex differences in the central nervous system. Ann Rev Neurosci. 1984;7:413-442.
16. Rhees RW, Shryne JE, Gorski RA. Onset of the hormonesensitive perinatal period for sexual differentiation of the sexually dimorphic nucleus of the preoptic area in female rats. J Neurobiol. 1990;21:781-786.
17. Phoenix CH, Goy RW, Gerall AA, Young WC. Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology. 1959;65:369-382.
18. Sisk CL, Zehr JL. Pubertal hormones organize the adolescent brain and behavior. Front Neuroendocrinol. 2005;26:163-174.
19. Arnold A. Concepts of genetic and hormonal induction of vertebrate sexual differentiation in the 20th century, with special reference to the brain. In: PfaffDW, Arnold A, Etgen A, Fahrbach S, Rubin R, eds. Hormones, Brain and Behavior. Vol 4. San Diego, CA: Academic Press; 2002: 105-136.
20. De Vries GJ, Simerly R. Anatomy, development and function of sexually dimorphic neural circuits in the mammalian brain. In: PfaffDW, Arnold A, Etgen A, Fahrbach S, Rubin R, eds. Hormones, Brain and Behavior. Vol 4. San Diego, CA: Academic Press; 2002:137-191.
21. McEwen BS, Lieberburg I, Chaptal C, Krey LC. Aromatization: important for sexual differentiation of the neonatal rat brain. Horm Behav. 1977;9:249-263.
22. McCarthy MM, Wright CL, Konkle ATM. Aromatase and sexual differentiation of the rodent brain. The old, the new and the unexpected In: Balthazart J, Ball GF, eds. Brain Aromatase, Estrogens and Behavior. New York, NY: Oxford University Press; 2012:315-336.
23. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62:847-855.
24. Giedd JN, Castellanos FX, Rajapakse JC, Vaituzis AC, Rapoport JL. Sexual dimorphism of the developing human brain. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1185-1201.
25. Cohen-Bendahan CC, Buitelaar JK, van Goozen SH, Cohen-Kettenis PT. Prenatal exposure to testosterone and functional cerebral lateralization: a study in same-sex and opposite-sex twin girls. Psychoneuroendocrinology. 2004;29:911-916.
26. Nopoulos P, Flaum M, O'Leary D, Andreasen NC. Sexual dimorphism in the human brain: evaluation of tissue volume, tissue composition and surface anatomy using magnetic resonance imaging. Psychiatry Res. 2000;98:1-13.
27. Swaab DF. Development of the human hypothalamus. Neurochem Res. 1995;20:509-519.
28. Duarte-Carvajalino JM, Jahanshad N, Lenglet C, et al. Hierarchical topological network analysis of anatomical human brain connectivity and differences related to sex and kinship. NeuroImage. 2012;59:3784-3804.
29. Wisniewski AB. Sexually-dimorphic patterns of cortical asymmetry, and the role for sex steroid hormones in determining cortical patterns of lateralization. Psychoneuroendocrinology. 1998;23:519-547.
30. Myren M, Mose T, Mathiesen L, Knudsen LE. The human placenta-an alternative for studying foetal exposure. Toxicology In Vitro. 2007;21:1332-1340.
31. Goodman A, Schorge J, Greene MF. The long-term effects of in utero exposures-the DES story. N Engl J Med. 2011;364:2083-2084.
32. Strohsnitter WC, Noller KL, Hoover RN, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001;93:545-551.
33. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology. 2012;153:4097-4110.
34. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect. 1996;104(Suppl 4): 715-740.
35. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT, eds. State of the Science of Endocrine Disrupting Chemicals. Geneva, Switzerland: United Nations Environment Programme and the World Health Organization; 2013.
36. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine Rev. 2009;30:293-342.
37. Thornton JW. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci U S A. 2001;98:5671-5676.
38. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol. 2008;22:2116-2127.
39. Aldad TS, Rahmani N, Leranth C, Taylor HS. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril. 2011;96:175-179.
40. Agras K, Shiroyanagi Y, Baskin LS. Progesterone receptors in the developing genital tubercle: implications for the endocrine disruptor hypothesis as the etiology of hypospadias. J Urol. 2007;178:722-727.
41. Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Environmental Health; 2009.
42. Third National Report on Human Exposure to Environmental Chemicals. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Environmental Health; 2005.
43. Skakkebaek NE, Toppari J, Söder O, Gordon CM, Divall S, Draznin M. The exposure of fetuses and children to endocrine disrupting chemicals: a European Society for Paediatric Endocrinology (ESPE) and Pediatric Endocrine Society (PES) call to action statement. J Clin Endocrinol Metab. 2011;96:3056-3058.
44. Meeker JD. Exposure to environmental endocrine disruptors and child development. Arch Pediatr Adolesc Med. 2012;166:952-958.
45. Li W, Chen B, Ding X. Environment and reproductive health in China: challenges and opportunities. Environ Health Perspect. 2012;120:A184-185.
46. Costa LG, Giordano G, Tagliaferri S, Caglieri A, Mutti A. Polybrominated diphenyl ether (PBDE) flame retardants: environmental contamination, human body burden and potential adverse health effects. Acta Biomed. 2008;79:172-183.
47. Zota AR, Park JS, Wang Y, Petreas M, Zoeller RT, WoodruffTJ. Polybrominated diphenyl ethers, hydroxylated polybrominated diphenyl ethers, and measures of thyroid function in second trimester pregnant women in California. Environ Sci Technol. 2011;45:7896-7905.
48. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116:39-44.
49. Braun JM, Kalkbrenner AE, Calafat AM, et al. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics. 2011;128:873-882.
50. Lang IA, Galloway TS, Scarlett A, et al. Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults. JAMA. 2008;300:1303-1310.
51. Chevrier C, Limon G, Monfort C, et al. Urinary biomarkers of prenatal atrazine exposure and adverse birth outcomes in the PELAGIE birth cohort. Environ Health Perspect. 2011;119:1034-1041.
52. Harley KG, Gunier RB, Kogut K, et al. Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ Res. 2013;126:43-50.
53. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA. 2012;308:1113-1121.
54. Trasande L, Attina TM, Trachtman H. Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney Int. 2013;83:741-748.
55. Trasande L, Spanier AJ, Sathyanarayana S, Attina TM, Blustein J. Urinary phthalates and increased insulin resistance in adolescents. Pediatrics. 2013;132:e646-e655.
56. Gerona RR, WoodruffTJ, Dickenson CA, et al. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ Sci Technol. 2013;47:12477-12485.
57. Minh TB, Watanabe M, Kajiwara N, et al. Human blood monitoring program in Japan: Contamination and bioaccumulation of persistent organochlorines in Japanese residents. Arch Environ Contam Toxicol. 2006;51:296-313.
58. Gladen BC, Doucet J, Hansen LG. Assessing human polychlorinated biphenyl contamination for epidemiologic studies: lessons from patterns of congener concentrations in Canadians in 1992. Environ Health Perspect. 2003;111:437-443.
59. Buck Louis GM, Sundaram R, Schisterman EF, et al. Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect. 2013;121:231-236.
60. Cupul-Uicab LA, KlebanoffMA, Brock JW, Longnecker MP. Prenatal exposure to persistent organochlorines and childhood obesity in the US collaborative perinatal project. Environ Health Perspect. 2013;121:1103-1109.
61. Maisonet M, Terrell ML, McGeehin MA, et al. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect. 2012;120:1432-1437.
62. Kim Y, Ha EH, Kim EJ, et al. Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children's Environmental Health (MOCEH) study. Environ Health Perspect. 2011;119:1495-1500.
63. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113:1056-1061.
64. Whyatt RM, Camann DE, Kinney PL, et al. Residential pesticide use during pregnancy among a cohort of urban minority women. Environ Health Perspect. 2002;110:507-514.
65. Buck Louis GM, Sundaram R, Sweeney AM, Schisterman EF, Maisog J, Kannan K. Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril. 2014;101:1359-1366.
66. Grandjean P, Bellinger D, Bergman A, et al. The Faroes Statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol. 2008;102:73-75.
67. Quinn CL, Wania F, Czub G, Breivik K. Investigating intergenerational differences in human PCB exposure due to variable emissions and reproductive behaviors. Environ Health Perspect. 2011;119:641-646.
68. Aoki Y. Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, and polychlorinated dibenzofurans as endocrine disrupters-what we have learned from Yusho disease. Environ Res. 2001;86:2-11.
69. Pesatori AC, Consonni D, Bachetti S, et al. Shortand longterm morbidity and mortality in the population exposed to dioxin after the "Seveso Accident." Ind Health. 2003;41:127-138.
70. Dickerson SM, Gore AC. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle. Rev Endocr Metab Disord. 2007;8:143-159.
71. Gore AC. Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front Neuroendocrinol. 2008;29:358-374.
72. Pravettoni A, Colciago A, Negri-Cesi P, Villa S, Celotti F. Ontogenetic development, sexual differentiation, and effects of Aroclor 1254 exposure on expression of the arylhydrocarbon receptor and of the arylhydrocarbon receptor nuclear translocator in the rat hypothalamus. Reprod Toxicol. 2005;20:521-530.
73. Hany J, Lilienthal H, Sarasin A, et al. Developmental exposure of rats to a reconstituted PCB mixture or aroclor 1254: effects on organ weights, aromatase activity, sex hormone levels, and sweet preference behavior. Toxicol Appl Pharmacol. 1999;158:231-243.
74. Lichtensteiger W, Faass O, Ma R, Schlumpf M. Effect of polybrominated diphenylether and PCB on the development of the brain-gonadal axis and gene expression in rats. Organohalog Compd. 2003;61:84-87.
75. Dickerson SM, Cunningham SL, Patisaul HB, Woller MJ Gore AC. Endocrine disruption of brain sexual differentiation by developmental PCB exposure. Endocrinology. 2011;152:581-594.
76. Dickerson SM, Cunningham SL, Gore AC. Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus. Toxicol Appl Pharmacol. 2011;252:36-46.
77. Walker DM, Goetz BM, Gore AC. Dynamic postnatal developmental and sex-specific neuroendocrine effects of prenatal polychlorinated biphenyls in rats. Mol Endocrinol. 2014;28:99-115.
78. Ikeda M, Mitsui T, Setani K, et al. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats disrupts brain sexual differentiation. Toxicol Appl Pharmacol. 2005;205:98-105.
79. Patisaul HB, Fortino AE, Polston EK. Neonatal genistein or bisphenol-A exposure alters sexual differentiation of the AVPV. Neurotoxicol Teratol. 2006;28:111-118.
80. Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, Ronsheim PM, Soto AM. Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology. 2006;147:3681-3691.
81. Colciago A, Negri-Cesi P, Pravettoni A, Mornati O, Casati L, Celotti F. Prenatal Aroclor 1254 exposure and brain sexual differentiation: effect on the expression of testosterone metabolizing enzymes and androgen receptors in the hypothalamus of male and female rats. Reprod Toxicol. 2006;22:738-745.
82. Shibutani M, Masutomi N, Uneyama C, et al. Down-regulation of GAT-1 mRNA expression in the microdissected hypothalamic medial preoptic area of rat offspring exposed maternally to ethinylestradiol. Toxicology. 2005;208:35-48.
83. Salama J, Chakraborty TR, Ng L, Gore AC. Effects of polychlorinated biphenyls on female reproductive development and estrogen receptor-beta expressionin the anteroventral periventricular nucleus. Environ Health Perspect. 2003;111:1278-1282.
84. Walker DM, Kermath BA, Woller MJ, Gore AC. Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors. Endocrinology. 2013;154:2129-2143.
85. Monje L, Varayoud J, Luque EH, Ramos JG. Neonatal exposure to bisphenol A modifies the abundance of estrogen receptor alpha transcripts with alternative 5'-untranslated regions in the female rat preoptic area. J Endocrinol. 2007;194:201-212.
86. Connors SL, Levitt P, Matthews SG, et al. Fetal mechanisms in neurodevelopmental disorders. Pediatr Neurol. 2008;38:163-176.
87. Lein PJ, Yang D, Bachstetter AD, et al. Ontogenetic alterations in molecular and structural correlates of dendritic growth after developmental exposure to polychlorinated biphenyls. Environ Health Perspect. 2007;115:556-563.
88. Willingham EJ. Trenbolone and other cattle growth promoters: need for a new risk-assessment framework. Environ Pract. 2006;8:58-65.
89. Besse JP, Garric J. Progestagens for human use, exposure and hazard assessment for the aquatic environment. Environ Pollut. 2009;157:3485-3494.
90. Tyler CR, Jobling S, Sumpter JP. Endocrine disruption in wildlife: a critical review of the evidence. Crit Rev Toxicol. 1998;28:319-361.
91. Kang JH, Asai D, Katamaya Y. Bisphenol A in the aquatic environment and its endocrine-disruptive effects on aquatic organisms. Crit Rev Toxicol. 2007;37:607-625.
92. Zala SM, Penn DJ. Abnormal behaviours induced by chemical pollution: a review of the evidence and new challenges. Anim Behav. 2004;68:649-664.
93. Kidd KA, Blanchfield PJ, Mills KH, et al. Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci U S A. 2007;104:8897-8901.
94. Wirgin I, Roy NK, Loftus M, Chambers RC, Franks DG, Hahn ME. Mechanistic basis of resistance to PCBs in Atlantic tomcod from the Hudson River. Science. 2011;331:1322-1325.
95. Cheshenko K, Pakdel F, Segner H, Kah O, Eggen RI. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish. Gen Comp Endocrinol. 2008;155:31-62.
96. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose response. Endocr Rev. 2012;33:378-455.
97. Barker DJ. The developmental origins of adult disease. Eur J Epidemiol. 2003;18:733-736.
98. Isgor C, Sengelaub DR. Prenatal gonadal steroids affect adult spatial behavior, CA1 and CA3 pyramidal cell morphology in rats. Horm Behav. 1998;34:183-198.
99. Williams CL, Barnett AM, Meck WH. Organizational effects of early gonadal secretions on sexual differentiation in spatial memory. Behav Neurosci. 1990;104:84-97.
100. Paris JJ, Brunton PJ, Russell JA, Walf AA, Frye CA. Inhibition of 5α-reductase activity in late pregnancy decreases gestational length and fecundity and impairs object memory and central progestogen milieu of juvenile rat offspring. J Neuroendocrinol. 2011;23:1079-1090.
101. De Vries GJ, Panzica GC. Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints. Neuroscience. 2006;138:947-955.
102. Carter CS, Grippo AJ, Pournajafi-Nazarloo H, Ruscio MG, Porges SW. Oxytocin, vasopressin and sociality. Prog Brain Res. 2008;170:331-336.
103. Donaldson ZR, Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science. 2008;322:900-904.
104. Shughrue PJ, Dellovade TL, Merchenthaler I. Estrogen modulates oxytocin gene expression in regions of the rat supraoptic and paraventricular nuclei that contain estrogen receptor-beta. Prog Brain Res. 2002;139:15-29.
105. Lonstein JS, Rood BD, De Vries GJ. Unexpected effects of perinatal gonadal hormone manipulations on sexual differentiation of the extrahypothalamic arginine-vasopressin system in prairie voles. Endocrinology. 2005;146:1559-1567.
106. Han TM, De Vries GJ. Organizational effects of testosterone, estradiol, and dihydrotestosterone on vasopressin mRNA expression in the bed nucleus of the stria terminalis. J Neurobiol. 2003;54:502-510.
107. Jurkevich A, Grossmann R, Balthazart J, Viglietti-Panzica C. Gender-related changes in the avian vasotocin system during ontogeny. Microsc Res Tech. 2001;55:27-36.
108. Carter DA, Saridaki E, Lightman SL. Sexual differentiation of oxytocin stress responsiveness: effect of neonatal androgenization, castration and a luteinizing hormone-releasing hormone antagonist. Acta Endocrinol. 1988;117:525-530.
109. Auger AP, Olesen KM. Brain sex differences and the organisation of juvenile social play behaviour. J Neuroendocrinol. 2009;21:519-525.
110. Schantz SL, Widholm JJ. Cognitive effects of endocrinedisrupting chemicals in animals. Environ Health Perspect. 2001;109:1197-1206.
111. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet. 2006;368:2167-2178.
112. Weiss B. Sexually dimorphic nonreproductive behaviors as indicators of endocrine disruption. Environ Health Perspect. 2002;110(Suppl 3):387-391.
113. Tian YH, Baek JH, Lee SY, Jang CG. Prenatal and postnatal exposure to bisphenol a induces anxiolytic behaviors and cognitive deficits in mice. Synapse. 2010;64:432-439.
114. Wolstenholme JT, Taylor JA, Shetty SR, Edwards M, Connelly JJ, Rissman EF. Gestational exposure to low dose bisphenol A alters social behavior in juvenile mice. PLos One. 2011;6:e25448.
115. Jašarevic E, Sieli PT, Twellman EE, et al. Disruption of adult expression of sexually selected traits by developmental exposure to bisphenol A. Proc Natl Acad Sci U S A. 2011;108:11715-11720.
116. Dingemans MM, van den Berg M, Westerink RH. Neurotoxicity of brominated flame retardants: (in)direct effects of parent and hydroxylated polybrominated diphenyl ethers on the (developing) nervous system. Environ Health Perspect. 2011;119:900-907.
117. Colciago A, Casati L, Mornati O, et al. Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat. Part 2: Effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring. Toxicol Appl Pharmacol. 2009;239:46-54.
118. Engell MD, Godwin J, Young LJ, Vandenbergh JG. Perinatal exposure to endocrine disrupting compounds alters behavior and brain in the female pine vole. Neurotoxicol Teratol. 2006;28:103-110.
119. Patisaul HB, Sullivan AW, Radford ME, et al. Anxiogenic effects of developmental bisphenol A exposure are associated with gene expression changes in the juvenile rat amygdala and mitigated by soy. PLos One. 2012;7: e43890.
120. Kundakovic M, Gudsnuk K, Franks B, et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci U S A. 2013;110:9956-9961.
121. Kubo K, Arai O, Omura M, Watanabe R, Ogata R, Aou S. Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats. Neurosci Res. 2003;45:345-356.
122. Carbone S, Ponzo OJ, Gobetto N, et al. Antiandrogenic effect of perinatal exposure to the endocrine disruptor di- (2-ethylhexyl) phthalate increases anxiety-like behavior in male rats during sexual maturation. Horm Behav. 2013;63:692-699.
123. Jolous-Jamshidi B, Cromwell HC, McFarland AM, Meserve LA. Perinatal exposure to polychlorinated biphenyls alters social behaviors in rats. Toxicol Lett. 2010;199:136-143.
124. Ehrhardt AA, Meyer-Bahlburg HF. Effects of prenatal sex hormones on gender-related behavior. Science. 1981;211:1312-1318.
125. Crews D. Epigenetics and its implications for behavioral neuroendocrinology. Front Neuroendocrinol. 2008;29:344-357.
126. Crews D, McLachlan JA. Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology. 2006;147: S4-10.
127. Wizemann TM, Pardue ML. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: Board on Health Sciences Policy, Institute of Medicine; 2001.
128. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med. 1996;335:783-789.
129. Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ, Weisglas-Kuperus N. Effects of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at 42 months of age. J Pediatr. 1999;134:33-41.
130. Darvill T, Lonky E, Reihman J, Stewart P, Pagano J. Prenatal exposure to PCBs and infant performance on the fagan test of infant intelligence. Neurotoxicology. 2000;21:1029-1038.
131. Lai TJ, Guo YL, Guo NW, Hsu CC. Effect of prenatal exposure to polychlorinated biphenyls on cognitive development in children: a longitudinal study in Taiwan. Br J Psychiatry Suppl. 2001;40:s49-s52.
132. Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MA, Van der Paauw CG, Tuinstra LG, Sauer PJ. Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants' mental and psychomotor development. Pediatrics. 1996;97:700-706.
133. Horton MK, Kahn LG, Perera F, Barr DB, Rauh V. Does the home environment and the sex of the child modify the adverse effects of prenatal exposure to chlorpyrifos on child working memory? Neurotoxicol Teratol. 2012;34:534-541.
134. Braun JM, Kalkbrenner AE, Just AC, et al. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4-and 5-year-old children: the HOME Study. Environ Health Perspect. 2014;122:513-520.
135. Shelton JF, Geraghty EM, Tancredi DJ, et al. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE Study. Environ Health Perspect. 2014;122:1103-1109.
136. Wing L. Sex ratios in early childhood autism and related conditions. Psychiatry Res. 1981;5:129-137.
137. PfaffDW, Rapin I, Goldman S. Male predominance in autism: neuroendocrine influences on arousal and social anxiety. Autism Res. 2011;4:163-176.
138. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: implications for explaining autism. Science. 2005;310:819-823.
139. Knickmeyer RC, Baron-Cohen S. Fetal testosterone and sex differences in typical social development and in autism. J Child Neurol. 2006;21:825-845.
140. Khan A, Harney JW, Zavacki AM, Sajdel-Sulkowska EM. Disrupted brain thyroid hormone homeostasis and altered thyroid hormone-dependent brain gene expression in autism spectrum disorders. J Physiol Pharmacol. 2014;65:257-272.
141. Andersen S, Laurberg P, Wu C, Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014;121:1365-1374.
142. Wudy SA, Dörr HG, Solleder C, Djalali M, Homoki J. Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentrations in fetuses at risk for 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1999;84:2724-2728.
143. Azziz R, Slayden SM. The 21-hydroxylase-deficient adrenal hyperplasias: more than ACTH oversecretion. J Soc Gynecol Investig. 1996;3:297-302.
144. Cohen-Bendahan CC, van de Beek C, Berenbaum SA. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev. 2005;29:353-384.
145. Hines M, Brook C, Conway GS. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J Sex Res. 2004;41:75-81.
146. Hines M. Prenatal endocrine influences on sexual orientation and on sexually differentiated childhood behavior. Front Neuroendocrinol. 2011;32:170-182.
147. Knickmeyer R, Baron-Cohen S, Fane BA, et al. Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia. Horm Behav. 2006;50:148-153.
148. Berenbaum SA, Hines M. Early androgens are related to childhood sex-typed toy preferences. Psychol Sci. 1992;3:203-206.
149. Hines M, Kaufman FR. Androgen and the development of human sex-typical behavior: rough-and-tumble play and sex of preferred playmates in children with congenital adrenal hyperplasia (CAH). Child Dev. 1994;65:1042-1053.
150. Hines M, Fane BA, Pasterski VL, Mathews GA, Conway GS, Brook C. Spatial abilities following prenatal androgen abnormality: targeting and mental rotations performance in individuals with congenital adrenal hyperplasia. Psychoneuroendocrinology. 2003;28:1010-1026.
151. McGuire LS, Ryan KO, Omenn GS. Congenital adrenal hyperplasia. II. Cognitive and behavioral studies. Behav Genet. 1975;5:175-188.
152. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31:5-17.
153. Rutter M. Diagnosis and definition of childhood autism. J Autism Child Schizophr. 1978;8:139-161.
154. Wing L, Gould J. Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification. J Autism Dev Disord. 1979;9:11-29.
155. Palomba S, Marotta R, Di Cello A, et al. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. Clin Endocrinol (Oxf). 2012;77:898-904.
156. Ehrhardt AA, Grisanti GC, Meyer-Bahlburg HF. Prenatal exposure to medroxyprogesterone acetate (MPA) in girls. Psychoneuroendocrinology. 1977;2:391-398.
157. Reinisch JM. Prenatal exposure of human foetuses to synthetic progestin and oestrogen affects personality. Nature. 1977;266:561-562.
158. Middelburg KJ, Heineman MJ, Bos AF, Hadders-Algra M. Neuromotor, cognitive, language and behavioural outcome in children born following IVF or ICSI-a systematic review. Hum Reprod Update. 2008;14:219-231.
159. Maimburg RD, Vaeth M. Do children born after assisted conception have less risk of developing infantile autism? Hum Reprod. 2007;22:1841-1843.
160. Hvidtjørn D, Grove J, Schendel D, et al. Risk of autism spectrum disorders in children born after assisted conception: a population-based follow-up study. J Epidemiol Community Health. 2011;65:497-502.
161. Lyall K, Pauls DL, Santangelo SL, Spiegelman D, Ascherio A. Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the nurses health study II. J Autism Dev Disord. 2011;41:618-627.
162. Lyall K, Pauls DL, Spiegelman D, Santangelo SL, Ascherio A. Fertility therapies, infertility and autism spectrum disorders in the Nurses' Health Study II. Paediatr Perinat Epidemiol. 2012;26:361-372.
163. Kelley RI, Hennekam RC. Smith-Lemli-Opitz syndrome. In: Scriver CR, Beudet al, Valle D, Sly WS, eds. The Metabolic and Molecular Basis of Inherited Disease. New York, NY: McGraw-Hill; 2001:6183-6201.
164. Marcos J, Guo LW, Wilson WK, Porter FD, Shackleton C. The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production. Steroids. 2004;69:51-60.
165. Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet Part A. 2006;140:1511-1518.
166. Whitehouse AJ, Maybery MT, Hart R, et al. Fetal androgen exposure and pragmatic language ability of girls in middle childhood: implications for the extreme male-brain theory of autism. Psychoneuroendocrinology. 2010;35:1259-1264.
167. Jacklin CN, Maccoby EE, Doering CH. Neonatal sex-steroid hormones and timidity in 6-18-month-old boys and girls. Dev Psychobiol. 1983;16:163-168.
168. Jacklin CN, Wilcox KT, Maccoby EE. Neonatal sex-steroid hormones and cognitive abilities at six years. Dev Psychobiol. 1988;21:567-574.
169. Marcus J, Maccoby EE, Jacklin CN, Doering CH. Individual differences in mood in early childhood: their relation to gender and neonatal sex steroids. Dev Psychobiol. 1985;18:327-340.
170. Hines M, Golombok S, Rust J, Johnston KJ, Golding J. Testosterone during pregnancy and gender role behavior of preschool children: a longitudinal, population study. Child Dev. 2002;73:1678-1687.
171. Finegan JA, Bartleman B, Wong PY. A window for the study of prenatal sex hormone influences on postnatal development. J Genet Psychol. 1989;150:101-112.
172. Finegan JA, Niccols GA, Sitarenios G. Relations between prenatal testosterone levels and cognitive abilities at 4 years. Dev Psychol. 1992;28:1075-1089.
173. Grimshaw GM, Bryden MP, Finegan JA. Relations between prenatal testosterone and cerebral lateralization in children. Neuropsychology. 1995;9:68-79.
174. Grimshaw GM, Sitarenios G, Finegan JA. Mental rotation at 7 years: relations with prenatal testosterone levels and spatial play experiences. Brain Cogn. 1995;29:85-100.
175. Escalante-Mead PR, Minshew NJ, Sweeney JA. Abnormal brain lateralization in high-functioning autism. J Autism Dev Disord. 2003;33:539-543.
176. Lutchmaya S, Baron-Cohen S, Raggatt P. Foetal testosterone and eye contact in 12-month-old human infants. Infant Behav Dev. 2002;25:327-335.
177. Knickmeyer R, Baron-Cohen S, Raggatt P, Taylor K. Foetal testosterone, social relationships, and restricted interests in children. J Child Psychol Psychiatry. 2005;46:198-210.
178. Knickmeyer R, Baron-Cohen S, Raggatt P, Taylor K, Hackett G. Fetal testosterone and empathy. Horm Behav. 2006;49:282-292.
179. Auyeung B, Baron-Cohen S, Ashwin E, et al. Fetal testosterone predicts sexually differentiated childhood behavior in girls and in boys. Psychol Sci. 2009;20:144-148.
180. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G. Fetal testosterone and autistic traits. Br J Psychol. 2009;100:1-22.
181. Auyeung B, Taylor K, Hackett G, Baron-Cohen S. Foetal testosterone and autistic traits in 18 to 24-month-old children. Mol Autism. 2010;1:11.
182. Auyeung B, Knickmeyer R, Ashwin E, Taylor K, Hackett G, Baron-Cohen S. Effects of fetal testosterone on visuospatial ability. Arch Sex Behav. 2012;41:571-581.
183. White SJ, Saldaña D. Performance of children with autism on the Embedded Figures Test: a closer look at a popular task. J Autism Dev Disord. 2011;41:1565-1572.
184. Baron-Cohen S, Auyeung B, Norgaard-Pedersen B, et al. Elevated fetal steroidogenic activity in autism. Mol Psychiatry. doi: 10.1038/mp.2014.48. [Epub ahead of print, June 3, 2014]
185. PfaffDW, Phillips I, Rubin R. Principles of Hormone/Behavior Relations. San Diego, CA: Academic Press/Elsevier; 2004.
186. Gagnidze K, PfaffDW. Epigenetic mechanisms: DNA methylation and histone protein modification. In: PfaffDW, ed. Neuroscienceinthe 21st Century. New York, NY: Springer; 2013:1-55.
187. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389:349-352.
188. Turner BM. Histone acetylation and an epigenetic code. BioEssays. 2000;22:836-845.
189. Berger SL. The complex language of chromatin regulation during transcription. Nature. 2007;447:407-412.
190. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol. 2005;6:838-849.
191. Koshland D, Strunnikov A. Mitotic chromosome condensation. Annu Rev Cell Dev Biol. 1996;12:305-333.
192. Mahadevan LC, Willis AC, Barratt MJ. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell. 1991;65:775-783.
193. Wolffe AP, Hayes JJ. Chromatin disruption and modification. Nucleic Acids Res. 1999;27:711-720.
194. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41-45.
195. Latham JA, Dent SY. Cross-regulation of histone modifications. Nat Struct Mol Biol. 2007;14:1017-1024.
196. Gagnidze K, PfaffDW. Hormone-dependent chromatin modifications regulating sexually differentiated animal behavior. In: PfaffDW, Christen Y, eds. Multiple Origins of Sex Differences in Brain: Neuroendocrine Functions and their Pathologies. New York, NY: Springer; 2013:1-20.
197. Tsai HW, Grant PA, Rissman EF. Sex differences in histone modifications in the neonatal mouse brain. Epigenetics. 2009;4:47-53.
198. Murray EK, Hien A, de Vries GJ, Forger NG. Epigenetic control of sexual differentiation of the bed nucleus of the stria terminalis. Endocrinology. 2009;150:4241-4247.
199. Murray EK, Varnum MM, Fernandez JL, de Vries GJ, Forger NG. Effects of neonatal treatment with valproic acid on vasopressin immunoreactivity and olfactory behaviour in mice. J Neuroendocrinol. 2011;23:906-914.
200. Jašarevic E, Geary DC, Rosenfeld CS. Sexually selected traits: a fundamental framework for studies on behavioral epigenetics. ILAR J. 2012;53:253-269.
201. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324:929-930.
202. Auger AP, Auger CJ. Epigenetic turn ons and turn offs: chromatin reorganization and brain differentiation. Endocrinology. 2011;152:349-353.
203. Kurian JR, Olesen KM, Auger AP. Sex differences in epigenetic regulation of the estrogen receptor-alpha promoter within the developing preoptic area. Endocrinology. 2010;151:2297-2305.
204. Nugent BM, Schwarz JM, McCarthy MM. Hormonally mediated epigenetic changes to steroid receptors in the developing brain: implications for sexual differentiation. Horm Behav. 2011;59:338-344.
205. Kundakovic M, Champagne FA. Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun. 2011;25:1084-1093.
206. Gore AC, Walker DM, Zama AM, Armenti AE, Uzumcu M. Early life exposure to endocrine-disrupting chemicals causes lifelong molecular reprogramming of the hypothalamus and premature reproductive aging. Mol Endocrinol. 2011;25:2157-2168.
207. Schwarz JM, Nugent BM, McCarthy MM. Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span. Endocrinology. 2010;151:4871-4881.
208. Bernstein E, Allis CD. RNA meets chromatin. Genes Dev. 2005;19:1635-1655.
209. Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci. 2012;13:528-541.
210. Saxena A, Carninci P. Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs. BioEssays. 2011;33:830-839.
211. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904-914.
212. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science. 2008;322:750-756.
213. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311-1323.
214. Chaumeil J, Le Baccon P, Wutz A, Heard E. A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev. 2006;20:2223-2237.
215. Coufal NG, Garcia-Perez JL, Peng GE, et al. L1 retrotransposition in human neural progenitor cells. Nature. 2009;460:1127-1131.
216. Baillie JK, Barnett MW, Upton KR, et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature. 2011;479:534-537.
217. Muotri AR, Marchetto MC, Coufal NG, et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature. 2010;468:443-446.
218. Singer T, McConnell MJ, Marchetto MC, Coufal NG, Gage FH. LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurosci. 2010;33:345-354.
219. Mueller BR, Bale TL. Early prenatal stress impact on coping strategies and learning performance is sex dependent. Physiol Behav. 2007;91:55-65.
220. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci. 2008;28:9055-9065.
221. Morgan CP, Bale TL. Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage. J Neurosci. 2011;31:11748-11755.
222. Sangiao-Alvarellos S, Manfredi-Lozano M, Ruiz-Pino F, et al. Changes in hypothalamic expression of the Lin28/let-7 system and related microRNAs during postnatal maturation and after experimental manipulations of puberty. Endocrinology. 2013;154:942-955.
223. Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry. 2014;19:862-871.
224. Wong CC, Meaburn EL, Ronald A, et al. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol Psychiatry. 2014;19:495-503.
225. Aldinger KA, Plummer JT, Levitt P. Comparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene. J Neurodev Disord. 2013;5:15.
226. PfaffDW, Arnold A, Etgen A, Fahrbach S, Rubin R, eds. Hormones, Brain and Behavior. San Diego, CA: Academic Press/Elsevier; 2009.
227. Choleris E, Gustafsson JA, Korach KS, Muglia LJ, PfaffDW, Ogawa S. An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-α and -β) knockout mice. Proc Natl Acad Sci U S A. 2003;100:6192-6197.
228. Choleris E, Little SR, Mong JA, Puram SV, Langer R, PfaffDW. Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci U S A. 2007;104:4670-4675.
229. Kumsta R, Heinrichs M. Oxytocin, stress and social behavior: neurogenetics of the human oxytocin system. Curr Opin Neurobiol. 2013;23:11-16.
230. Gregory SG, Connelly JJ, Towers AJ, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 2009;7:62.
231. Mamrut S, Harony H, Sood R, et al. DNA methylation of specific CpG sites in the promoter region regulates the transcription of the mouse oxytocin receptor. PLoS One. 2013; 8:e56869.
232. Jack A, Connelly JJ, Morris JP. DNA methylation of the oxytocin receptor gene predicts neural response to ambiguous social stimuli. Front Hum Neurosci. 2012;6:280.
233. Rockman MV. The QTN program and the alleles that matter for evolution: all that's gold does not glitter. Evolution. 2012;66:1-17.
234. Crews D, Gore AC. Epigenetic synthesis: A need for a new paradigm for evolution in a contaminated world. F1000 Biol Rep. 2012;4:18.
235. Walker DM, Gore AC. Transgenerational neuroendocrine disruption of reproduction. Nat Rev Endocrinol. 2011;7:197-207.
236. Danchin É, Charmantier A, Champagne FA, Mesoudi A, Pujol B, Blanchet S. Beyond DNA: integrating inclusive inheritance into an extended theory of evolution. Nat Rev Genet. 2011;12:475-486.
237. Cameron NM, Shahrokh D, Del Corpo A, et al. Epigenetic programming of phenotypic variations in reproductive strategies in the rat through maternal care. J Neuroendocrinol. 2008;20:795-801.
238. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004;7:847-854.
239. Champagne FA. Epigenetic mechanisms and the transgenerational effects of maternal care. Front Neuroendocrinol. 2008;29:386-397.
240. Dettling AC, Feldon J, Pryce CR. Repeated parental deprivation in the infant common marmoset (Callithrix jacchus, primates) and analysis of its effects on early development. Biol Psychiatry. 2002;52:1037-1046.
241. Dettling AC, Schnell CR, Maier C, Feldon J, Pryce CR. Behavioral and physiological effects of an infant-neglect manipulation in a bi-parental, twinning primate: impact is dependent on familial factors. Psychoneuroendocrinology. 2007;32:331-349.
242. Yehuda R, Morris A, Labinsky E, Zemelman S, Schmeidler J. Ten-year follow-up study of cortisol levels in aging holocaust survivors with and without PTSD. J Trauma Stress. 2007;20:757-761.
243. Yehuda R, Teicher MH, Seckl JR, Grossman RA, Morris A, Bierer LM. Parental posttraumatic stress disorder as a vulnerability factor for low cortisol trait in offspring of holocaust survivors. Arch Gen Psychiatr. 2007;64:1040-1048.
244. Matthews SG, Phillips DI. Transgenerational inheritance of stress pathology. Exp Neurol. 2012;233:95-101.
245. GräffJ, Mansuy IM. Epigenetic codes in cognition and behaviour. Behav Brain Res. 2008;192:70-87.
246. Bohacek J, Gapp K, Saab BJ, Mansuy IM. Transgenerational epigenetic effects on brain functions. Biol Psychiatry. 2013;73:313-320.
247. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308:1466-1469.
248. Roemer I, Reik W, Dean W, Klose J. Epigenetic inheritance in the mouse. Curr Biol. 1997;7:277-280.
249. Stouder C, Paoloni-Giacobino A. Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm. Reproduction. 2010;139:373-379.
250. Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87:1111-1119.
251. Crews D, Gore AC, Hsu TS, et al. Transgenerational epigenetic imprints on mate preference. Proc Natl Acad Sci U S A. 2007;104:5942-5946.
252. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One. 2008;3: e3745.
253. Wolstenholme JT, Edwards M, Shetty SR, et al. Gestational exposure to bisphenol A produces transgenerational changes in behaviors and gene expression. Endocrinology. 2012;153:3828-3838.
254. Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK. Epigenetic transgenerational inheritance of altered stress responses. Proc Natl Acad SciUS A. 2012;109:9143-9148.
255. Gillette R, Miller-Crews I, Nilsson EE, Skinner MK, Gore AC, Crews D. Sexually dimorphic effects of ancestral exposure to vinclozolin on stress reactivity in rats. Endocrinology. 2014;155:3853-3866.
256. Faulk C, Dolinoy DC. Timing is everything: the when and how of environmentally induced changes in the epigenome of animals. Epigenetics. 2011;6:791-797.
257. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A. 2007;104:13056-13061.
258. Weaver IC, Champagne FA, Brown SE, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci. 2005;25:11045-11054.
259. Nadeau JH. Transgenerational genetic effects on phenotypic variation and disease risk. Hum Mol Genet. 2009; 18:R202-R210.
260. Ho DH, Burggren WW. Epigenetics and transgenerational transfer: a physiological perspective. J Exp Biol. 2010;213:3-16.
261. Dunn GA, Bale TL. Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice. Endocrinology. 2009;150:4999-5009.
262. Dunn GA, Bale TL. Maternal high-fat diet effects on thirdgeneration female body size via the paternal lineage. Endocrinology. 2011;152:2228-2236.
263. Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav. 2007;51:597-604.
264. Auyeung B, Ahluwalia J, Thomson L, et al. Prenatal versus postnatal sex steroid hormone effects on autistic traits in children at 18 to 24 months of age. Mol Autism. 2012;3:17.
265. Baron-Cohen S, Auyeung B, Nørgaard-Pedersen B, et al. Elevated fetal steroidogenic activity in autism. In: proceedings from the International Meeting for Autism Research, 2012; Toronto, Ontario, Canada. Abstract 104.002.
266. Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med. 2007;161:326-333.
267. Abdallah MW, Larsen N, Grove J, et al. Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav Immun. 2012;26:170-176.
268. Crews D, Gore AC. Life imprints: living in a contaminated world. Environ Health Perspect. 2011;119:1208-1210.
269. Landrigan PJ, Lambertini L, Birnbaum LS. A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities. Environ Health Perspect. 2012;120:a258-260.
270. Testa C, Nuti F, Hayek J, et al. Di-(2-ethylhexyl) phthalate and autism spectrum disorders. ASN Neuro. 2012;4:223-229.
271. Shelton JF, Hertz-Picciotto I, Pessah IN. Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect. 2012;120:944-951.
272. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, 2000.
273. Neel BA, Sargis RM. The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes. 2011;60:1838-1848.
274. Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics. 2011;127:1034-1042.
275. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853-858.
276. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14:1902-1910.
277. Hutvágner G, Zamore PD. A microRNA in a multipleturnover RNAi enzyme complex. Science. 2002;297:2056-2060.
278. O'Carroll D, Schaefer A. General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology. 2013;38:39-54.
279. Winneke G, Ranft U, Wittsiepe J, et al. Behavioral sexual dimorphism in school-age children and early developmental exposure to dioxins and PCBs: a follow-up study of the Duisburg Cohort. Environ Health Perspect. 2014;122:292-298.